Literature DB >> 132720

A sensitive micromethod for generating and assaying allogeneically induced cytotoxic human lymphocytes.

J M Zarling, M McKeough, F H Bach.   

Abstract

A sensitive micromethod for generating and assaying allogeneically induced cytotoxic human lymphocytes in vitro is described. Responding lymphocytes are cultured with mitomycin-C treated allogeneic stimulating cells in wells of replicate microtrays for both one-way mixed leukocyte culture (MLC) and cell-mediated lympholysis (CML) assays. On day 5, MLC response is determined by measuring 3H-thymidine (3H-TdR) incorporation directly in wells of the MLC tray. On day 6 or 7 CML response is determined by measuring 51Cr released from labeled target cells added to replicate culture cells in the CML tray. It is thus possible to measure both MLC and CML responses of the 2.5 X 10(4) -U X 10(5) responding lymphocytes originally placed in replicate wells. 51Cr-labeled target cells can be added to wells containing dilutions of the stimulated cells and a log-linear relationship between the per cent specific 51Cr release and number of effector cells is observed. Significant levels of specific cytoxicity are detected at ratios as low as one effector cell per target cell; little cross-killing on third-party cells and no autokilling is observed. Lymphocytes purified from whole blood that is stored overnight at room temperature and purified lymphocytes stored overnight in the cold generate MLC and CML responses comparable to those of lymphocytes purified from fresh blood. Only 2 or 3 ml of whole blood are required to perform both MLC and CML assays, thus enabling the study of both proliferative and cytotoxic lymphocyte responses in young children and other individuals from whom only a few milliliters of blood can be obtained.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 132720     DOI: 10.1097/00007890-197606000-00005

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Immunologic effects on peripheral lymphoid cells from patients with chronic hepatitis type B during administration of recombinant interleukin 2.

Authors:  S Yamaguchi; M Onji; H Kondoh; H Miyaoka; Y Ohta
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

2.  Activation of antigen-specific suppressor T cells in the presence of cyclosporin requires interactions between T cells of inducer and suppressor lineage.

Authors:  N Mohagheghpour; C J Benike; G Kansas; C Bieber; E G Engleman
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

3.  Non-specific inhibitory processes of immunological and mitogenic cellular responses.

Authors:  M Liacopoulos; F Lambert; P Liacopoulos
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

4.  Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines.

Authors:  J M Zarling; F H Bach
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

5.  Effect of recombinant interleukin 2 on hepatitis B e antigen positive chronic hepatitis.

Authors:  M Onji; H Kondoh; N Horiike; S Yamaguchi; Y Ogawa; I Kumon; Y Ohta
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

6.  Transplantation of cultured thymic fragments. II. Results in nude mice.

Authors:  R Hong; H Schulte-Wissermann; E Jarrett-Toth; S D Horowitz; D D Manning
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.